Recent studies have shown that certain proteins associated with atherosclerosis, inflammation, and endothelial damage, such as interleukin-6, MCP-3, and osteoprotegerin, accumulate in patients with pore shrinkage syndrome, which may lead to an increased burden of WMHV [16,27]. Here, TNFRSF11B is linked to atherosclerosis.